Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

Insider Trades & Whales

Insider trades are parsed from SEC Form 4 filings (first-party). The ownership breakdown below is computed first-hand from SEC 13F-HR + Form 4 (institutions from 13F, insiders from Form 4). For the full filer list and quarter-over-quarter position changes, see the Institutional (13F) tab.

Ownership Breakdown

Insiders 1.73%Institutions 8.39%46 filers

Top Institutions

Form 4 Transactions

18 most recent
DateInsiderTitleCodeSharesPriceValue
Jul 6, 2026Gupta SrishtiChief Executive OfficerA3,000,000$0.0000$0.00
Jul 6, 2026Xu Cong ClaireSVP, Clinical DevelopmentS4,485$0.8900$3.99K
Jul 4, 2026Xu Cong ClaireSVP, Clinical DevelopmentM5,405$0.0000$0.00
Jul 4, 2026Xu Cong ClaireSVP, Clinical DevelopmentM12,432––
Jun 29, 2026Fu WeiDirectorA1,010,100$0.0000$0.00
Jun 29, 2026Fu WeiDirectorA1,087,720$0.0000$0.00
Jun 29, 2026Fu WeiDirectorA1,087,720$0.0000$0.00
Jun 29, 2026Fu WeiDirectorA725,140$0.0000$0.00
Jun 22, 2026Cao Sean WuxiongChief Bus. Development OfficerA181,290$0.0000$0.00
Jun 22, 2026Cao Sean WuxiongChief Bus. Development OfficerA181,280$0.0000$0.00
Jun 18, 2026Dennis Phillip AndrewChief Medical OfficerS8,494$0.6600$5.61K
Jun 17, 2026Dennis Phillip AndrewChief Medical OfficerM10,302$0.0000$0.00
Jun 17, 2026Dennis Phillip AndrewChief Medical OfficerM23,695––
Jun 1, 2026Xu Cong ClaireSVP, Clinical DevelopmentS3,494$3.9400$13.77K
May 30, 2026Xu Cong ClaireSVP, Clinical DevelopmentM4,079$0.0000$0.00
May 30, 2026Xu Cong ClaireSVP, Clinical DevelopmentM9,382––
May 14, 2026Cao Sean WuxiongSee RemarksS21,399$1.9900$42.58K
Apr 24, 2026Hagler Mark ArnoldSee RemarksP230,000$2.5100$577.30K